Annual Net Income
-$6.68 M
+$87.93 M+92.93%
31 December 2023
Summary:
Entrada Therapeutics annual net profit is currently -$6.68 million, with the most recent change of +$87.93 million (+92.93%) on 31 December 2023. During the last 3 years, it has risen by +$19.84 million (+74.80%). TRDA annual net income is now -31.08% below its all-time high of -$5.10 million, reached on 31 December 2019.TRDA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$14.03 M
-$69.06 M-125.50%
30 September 2024
Summary:
Entrada Therapeutics quarterly net profit is currently -$14.03 million, with the most recent change of -$69.06 million (-125.50%) on 30 September 2024. Over the past year, it has dropped by -$49.49 million (-139.57%). TRDA quarterly net income is now -125.50% below its all-time high of $55.03 million, reached on 30 June 2024.TRDA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$54.95 M
-$49.49 M-47.39%
30 September 2024
Summary:
Entrada Therapeutics TTM net profit is currently $54.95 million, with the most recent change of -$49.49 million (-47.39%) on 30 September 2024. Over the past year, it has increased by +$76.72 million (+352.42%). TRDA TTM net income is now -47.39% below its all-time high of $104.44 million, reached on 30 June 2024.TRDA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRDA Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +92.9% | -139.6% | +352.4% |
| 3 y3 years | +74.8% | +2.8% | +232.8% |
| 5 y5 years | - | - | - |
TRDA Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +92.9% | -125.5% | +45.9% | -47.4% | +158.1% |
| 5 y | 5 years | -31.1% | +92.9% | -125.5% | +45.9% | -47.4% | +158.1% |
| alltime | all time | -31.1% | +92.9% | -125.5% | +45.9% | -47.4% | +158.1% |
Entrada Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$14.03 M(-125.5%) | $54.95 M(-47.4%) |
| June 2024 | - | $55.03 M(+134.2%) | $104.44 M(+344.7%) |
| Mar 2024 | - | $23.50 M(-346.2%) | $23.48 M(-451.3%) |
| Dec 2023 | -$6.68 M(-92.9%) | -$9.54 M(-126.9%) | -$6.68 M(-69.3%) |
| Sept 2023 | - | $35.46 M(-236.8%) | -$21.77 M(-73.6%) |
| June 2023 | - | -$25.93 M(+288.5%) | -$82.37 M(+3.5%) |
| Mar 2023 | - | -$6.67 M(-72.9%) | -$79.62 M(-15.9%) |
| Dec 2022 | -$94.62 M | -$24.63 M(-2.0%) | -$94.62 M(+7.0%) |
| Sept 2022 | - | -$25.14 M(+8.4%) | -$88.43 M(+13.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$23.18 M(+7.0%) | -$77.73 M(+20.6%) |
| Mar 2022 | - | -$21.67 M(+17.5%) | -$64.45 M(+26.0%) |
| Dec 2021 | -$51.16 M(+92.9%) | -$18.45 M(+27.8%) | -$51.16 M(+23.6%) |
| Sept 2021 | - | -$14.43 M(+45.7%) | -$41.38 M(+21.9%) |
| June 2021 | - | -$9.90 M(+18.2%) | -$33.94 M(+41.2%) |
| Mar 2021 | - | -$8.38 M(-3.4%) | -$24.04 M(+53.5%) |
| Dec 2020 | -$26.52 M(+420.1%) | -$8.67 M(+24.1%) | -$15.66 M(+124.1%) |
| Sept 2020 | - | -$6.99 M | -$6.99 M |
| Dec 2019 | -$5.10 M | - | - |
FAQ
- What is Entrada Therapeutics annual net profit?
- What is the all time high annual net income for Entrada Therapeutics?
- What is Entrada Therapeutics annual net income year-on-year change?
- What is Entrada Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly net income year-on-year change?
- What is Entrada Therapeutics TTM net profit?
- What is the all time high TTM net income for Entrada Therapeutics?
- What is Entrada Therapeutics TTM net income year-on-year change?
What is Entrada Therapeutics annual net profit?
The current annual net income of TRDA is -$6.68 M
What is the all time high annual net income for Entrada Therapeutics?
Entrada Therapeutics all-time high annual net profit is -$5.10 M
What is Entrada Therapeutics annual net income year-on-year change?
Over the past year, TRDA annual net profit has changed by +$87.93 M (+92.93%)
What is Entrada Therapeutics quarterly net profit?
The current quarterly net income of TRDA is -$14.03 M
What is the all time high quarterly net income for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly net profit is $55.03 M
What is Entrada Therapeutics quarterly net income year-on-year change?
Over the past year, TRDA quarterly net profit has changed by -$49.49 M (-139.57%)
What is Entrada Therapeutics TTM net profit?
The current TTM net income of TRDA is $54.95 M
What is the all time high TTM net income for Entrada Therapeutics?
Entrada Therapeutics all-time high TTM net profit is $104.44 M
What is Entrada Therapeutics TTM net income year-on-year change?
Over the past year, TRDA TTM net profit has changed by +$76.72 M (+352.42%)